Efficacy and Tolerability of Sensoril® in Improving Immunity and Thereby Reducing Incidence of Upper Respiratory Tract Infections

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
to assess the efficacy and safety of a standardized Withania somnifera extract (Sensoril®) as an immunomodulator in individuals suffering from recurrent URTIs. The study population will be administered with this unique blend of WS extract for 12 weeks and will be assessed as per the study designated efficacy and safety variables.
Epistemonikos ID: ee59a324fc4acb7f2edc96ac336d6ebff6334e88
First added on: May 08, 2024